Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127363851 | 12736385 | 1 | I | 20160802 | 20160830 | 20160913 | 20160913 | EXP | NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-123292 | RANBAXY | 55.00 | YR | M | Y | 0.00000 | 20160913 | OT | NO | NO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127363851 | 12736385 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 153 MG | Y | U | 202922 | 153 | MG | ||||||
127363851 | 12736385 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 153 MG | Y | U | 202922 | 153 | MG | ||||||
127363851 | 12736385 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 153 MG | Y | U | 202922 | 153 | MG | ||||||
127363851 | 12736385 | 4 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 100 MG | U | U | 0 | 100 | MG | ||||||
127363851 | 12736385 | 5 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 100 MG | U | U | 0 | 100 | MG | ||||||
127363851 | 12736385 | 6 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 100 MG | U | U | 0 | 100 | MG | ||||||
127363851 | 12736385 | 7 | SS | Fluoroblastin | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 900 MG | 0 | 900 | MG | ||||||||
127363851 | 12736385 | 8 | SS | Fluoroblastin | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 900 MG | 0 | 900 | MG | ||||||||
127363851 | 12736385 | 9 | SS | Fluoroblastin | FLUOROURACIL | 1 | Unknown | 900 MG | 0 | 900 | MG | ||||||||
127363851 | 12736385 | 10 | C | EMEND | APREPITANT | 1 | Unknown | 125 MG | U | U | 0 | 125 | MG | ||||||
127363851 | 12736385 | 11 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | 8 MG | U | U | 0 | 8 | MG | ||||||
127363851 | 12736385 | 12 | C | KLEXANE | ENOXAPARIN | 1 | Subcutaneous | 60 MG | U | U | 0 | 60 | MG | ||||||
127363851 | 12736385 | 13 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 16 MG | U | U | 0 | 16 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127363851 | 12736385 | 1 | Rectal cancer |
127363851 | 12736385 | 4 | Rectal cancer |
127363851 | 12736385 | 7 | Rectal cancer |
127363851 | 12736385 | 10 | Prophylaxis of nausea and vomiting |
127363851 | 12736385 | 11 | Premedication |
127363851 | 12736385 | 12 | Deep vein thrombosis |
127363851 | 12736385 | 13 | Premedication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127363851 | 12736385 | OT |
127363851 | 12736385 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127363851 | 12736385 | Abdominal pain upper | |
127363851 | 12736385 | Cold sweat | |
127363851 | 12736385 | Nausea | |
127363851 | 12736385 | Restlessness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127363851 | 12736385 | 1 | 20160802 | 0 | ||
127363851 | 12736385 | 2 | 20160705 | 0 | ||
127363851 | 12736385 | 3 | 20160704 | 0 | ||
127363851 | 12736385 | 4 | 20160705 | 0 | ||
127363851 | 12736385 | 5 | 20160704 | 0 | ||
127363851 | 12736385 | 6 | 20160802 | 0 | ||
127363851 | 12736385 | 7 | 20160705 | 0 | ||
127363851 | 12736385 | 8 | 20160704 | 0 | ||
127363851 | 12736385 | 9 | 20160802 | 0 |